Skip to content

Verification of Therapeutic effect of Intelligent Rehabilitation system on patients with early Stroke

Integration and Clinical Verification of severe Intelligent Rehabilitation system

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079594
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group:Conventional OT training
Multi-sensory stimulation group:Conventional OT training and Multi-sensory stimulation
BCI group:Conventional OT training and Brain-computer interface training

Sponsors

Beijing Tsinghua Changgeng Hospital, Tsinghua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) In accordance with the diagnostic criteria of stroke formulated by the fourth National Conference on Cerebrovascular Diseases, confirmed as stroke by head CT or MRI examination; (2) The first onset, the course of the disease is less than 1 month; (3) The age is 30-75 years old; (4) The vital signs are relatively stable, the consciousness is clear, and the listening comprehension is OK, can cooperate with the evaluation and test; (5) There is no progressive aggravation of stroke; other multi-system important organs are stable; (6) The study was approved by the ethics committee of our hospital, and the patients were treated voluntarily and all signed the informed consent form for treatment.

Exclusion criteria

Exclusion criteria: (1) Patients with disturbance of consciousness; (2) Complicated with other nervous system diseases; (3) Obvious cognitive impairment, mental symptoms, emotional disorders, etc., unable to cooperate with training and evaluation; (4) Severe heart, lung, liver, kidney and other important organ failure; (5) Previous history of epilepsy, or are taking antiepileptic drugs; (6) Patients' condition worsened with new infarction or increased volume of bleeding; (7) Obvious skull defect, or other factors affecting EEG during training; (8) Wearing pacemaker, intracranial metal implant and other internal metal implants; (9) those who are unwilling to accept this experiment or have difficulties in completing this experiment for various reasons.

Design outcomes

Primary

MeasureTime frame
FMA-UL;Hand practicality classification;MBI;EEG;

Secondary

MeasureTime frame
MMT;Modified Ashworth scale, MAS;Action Research Arm Test, ARAT;Wolf motor function test, WMFT;

Countries

China

Contacts

Public ContactPan Yu

Beijing Tsinghua Changgeng Hospital, Tsinghua University

panyu@btch.edu.cn+86 10 5611 9272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026